Westfield Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-545,976
Closed -$26.5M 236
2020
Q2
$26.5M Buy
545,976
+36,091
+7% +$1.73M 0.18% 143
2020
Q1
$21.5M Buy
+509,885
New +$21M 0.19% 135
2017
Q2
Sell
-238,694
Closed -$8.21M 251
2017
Q1
$8.21M Buy
+238,694
New +$8.43M 0.07% 215
2016
Q2
Sell
-13,450
Closed -$376K 258
2016
Q1
$376K Sell
13,450
-1,466,054
-99% -$32M ﹤0.01% 241
2015
Q4
$52.7M Buy
+1,479,504
New +$52.1M 0.36% 94
2014
Q3
Sell
-2,308,261
Closed -$52.1M 300
2014
Q2
$52.1M Sell
2,308,261
-39,150
-2% -$817K 0.31% 107
2014
Q1
$57.1M Sell
2,347,411
-623,630
-21% -$15.8M 0.34% 102
2013
Q4
$74.2M Buy
2,971,041
+910,490
+44% +$21.5M 0.44% 74
2013
Q3
$56.6M Buy
+2,060,551
New +$43.1M 0.36% 96

Other funds holding ACAD